ArticleActa diabetologica2025

Long-term efficacy of daily oral semaglutide as add-on or switch therapy in adults with type 2 diabetes: a 12-month real-world retrospective study.

Daniela Sansone et al.PubMed ↗Publisher ↗

No numbers read from the abstract.